 | Up a level |
Journal Article
Brown, Jennifer R., Eichhorst, Barbara, Ghia, Paolo, Kater, A. P., Li, Jianyong, Khurana, Sudha, Elhamy, Mostafa, Wang, Min Hui and Seymour, John F. (2020). Phase 3 Trial of Acalabrutinib in Combination with Venetoclax, With and Without Obinutuzumab Versus Chemoimmunotherapy for Previously Untreated Chronic Lymphocytic Leukemia (CLL). Clin. Lymphoma Myeloma Leuk., 20. S. S221 - 2. DALLAS: CIG MEDIA GROUP, LP. ISSN 2152-2669
Mobasher, Mehrdad, Huang, Jane, Elstrom, Rebecca L., Elhamy, Mostafa, Bernaards, Coen, Hallek, Michael J., Hillmen, Peter, Kater, Arnon Philip, Kipps, Thomas J. and Seymour, John Francis (2014). Multicenter, phase III, open-label, randomized study in relapsed/refractory CLI, to evaluate the benefit of GDC-0199 (ABT-199) plus rituximah compared with bendamustine plus rituximab. J. Clin. Oncol., 32 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755